These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11892787)

  • 1. Intramolecular binding of a proximal PPII helix to an SH3 domain in the fusion protein SH3Hck : PPIIhGAP.
    Gmeiner WH; Xu I; Horita DA; Smithgall TE; Engen JR; Smith DL; Byrd RA
    Cell Biochem Biophys; 2001; 35(2):115-26. PubMed ID: 11892787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disrupting the intramolecular interaction between proto-oncogene c-Src SH3 domain and its self-binding peptide PPII with rationally designed peptide ligands.
    Zhou P; Hou S; Bai Z; Li Z; Wang H; Chen Z; Meng Y
    Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1122-1131. PubMed ID: 28754059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Fluoroproline derivative peptides: effect on PPII conformation and SH3 affinity.
    Ruzza P; Siligardi G; Donella-Deana A; Calderan A; Hussain R; Rubini C; Cesaro L; Osler A; Guiotto A; Pinna LA; Borin G
    J Pept Sci; 2006 Jul; 12(7):462-71. PubMed ID: 16506148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the Src family kinase Hck SH3-SH2 linker regulatory region supports an SH3-dominant activation mechanism.
    Alvarado JJ; Betts L; Moroco JA; Smithgall TE; Yeh JI
    J Biol Chem; 2010 Nov; 285(46):35455-61. PubMed ID: 20810664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A miniprotein scaffold used to assemble the polyproline II binding epitope recognized by SH3 domains.
    Cobos ES; Pisabarro MT; Vega MC; Lacroix E; Serrano L; Ruiz-Sanz J; Martinez JC
    J Mol Biol; 2004 Sep; 342(1):355-65. PubMed ID: 15313630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure of "unstructured" regions in peptides and proteins: role of the polyproline II helix in protein folding and recognition.
    Rath A; Davidson AR; Deber CM
    Biopolymers; 2005; 80(2-3):179-85. PubMed ID: 15700296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution structure of the human Hck SH3 domain and identification of its ligand binding site.
    Horita DA; Baldisseri DM; Zhang W; Altieri AS; Smithgall TE; Gmeiner WH; Byrd RA
    J Mol Biol; 1998 Apr; 278(1):253-65. PubMed ID: 9571048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SH3 domain of a M7 interacts with its C-terminal proline-rich region.
    Wang Q; Deloia MA; Kang Y; Litchke C; Zhang N; Titus MA; Walters KJ
    Protein Sci; 2007 Feb; 16(2):189-96. PubMed ID: 17189480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions.
    Feng S; Chen JK; Yu H; Simon JA; Schreiber SL
    Science; 1994 Nov; 266(5188):1241-7. PubMed ID: 7526465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of either 4-R-hydroxyproline or 4-R-fluoroproline on the conformation and SH3m-cort binding of HPK1 proline-rich peptide.
    Borgogno A; Ruzza P
    Amino Acids; 2013 Feb; 44(2):607-14. PubMed ID: 22976002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A helical lock and key model of polyproline II conformation with SH3.
    Meirson T; Bomze D; Kahlon L; Gil-Henn H; Samson AO
    Bioinformatics; 2020 Jan; 36(1):154-159. PubMed ID: 31250908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grb2 SH3 binding to peptides from Sos: evaluation of a general model for SH3-ligand interactions.
    Simon JA; Schreiber SL
    Chem Biol; 1995 Jan; 2(1):53-60. PubMed ID: 9383403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the SH3 domain of human osteoclast-stimulating factor with rationally designed peptoid inhibitors.
    Han S; Liu Q; Wang F; Yuan Z
    J Pept Sci; 2016 Aug; 22(8):533-9. PubMed ID: 27443979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why the first self-binding peptide of human
    Zhou P; Yan F; Miao Q; Chen Z; Wang H
    J Biomol Struct Dyn; 2021 Jan; 39(1):310-318. PubMed ID: 31872783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mona/Gads SH3C binding to hematopoietic progenitor kinase 1 (HPK1) combines an atypical SH3 binding motif, R/KXXK, with a classical PXXP motif embedded in a polyproline type II (PPII) helix.
    Lewitzky M; Harkiolaki M; Domart MC; Jones EY; Feller SM
    J Biol Chem; 2004 Jul; 279(27):28724-32. PubMed ID: 15100220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topography for independent binding of alpha-helical and PPII-helical ligands to a peroxisomal SH3 domain.
    Douangamath A; Filipp FV; Klein AT; Barnett P; Zou P; Voorn-Brouwer T; Vega MC; Mayans OM; Sattler M; Distel B; Wilmanns M
    Mol Cell; 2002 Nov; 10(5):1007-17. PubMed ID: 12453410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for the binding of proline-rich peptides to SH3 domains.
    Yu H; Chen JK; Feng S; Dalgarno DC; Brauer AW; Schreiber SL
    Cell; 1994 Mar; 76(5):933-45. PubMed ID: 7510218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyproline-II helix in proteins: structure and function.
    Adzhubei AA; Sternberg MJ; Makarov AA
    J Mol Biol; 2013 Jun; 425(12):2100-32. PubMed ID: 23507311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Domain interactions in protein tyrosine kinase Csk.
    Sondhi D; Cole PA
    Biochemistry; 1999 Aug; 38(34):11147-55. PubMed ID: 10460171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory intramolecular association in a tyrosine kinase of the Tec family.
    Andreotti AH; Bunnell SC; Feng S; Berg LJ; Schreiber SL
    Nature; 1997 Jan; 385(6611):93-7. PubMed ID: 8985255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.